Deciphering the signaling pathways of cancer stem cells of glioblastoma multiforme: role of Akt/mTOR and MAPK pathways.
Jhanwar-Uniyal
Meena
M
Department of Neurosurgery, New York Medical College, Valhalla, NY 10595, USA. meena_jhanwar@nymc.edu
Albert
Ladislau
L
McKenna
Elise
E
Karsy
Michael
M
Rajdev
Priya
P
Braun
Alex
A
Murali
Raj
R
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000378:metabolism; D002070:Butadienes / Q000378:metabolism; D002460:Cell Line; D004791:Enzyme Inhibitors / Q000378:metabolism; D005909:Glioblastoma / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D020935:MAP Kinase Signaling System / Q000502:physiology*; D014411:Neoplastic Stem Cells / Q000502:physiology*; D009570:Nitriles / Q000378:metabolism; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology*; D020123:Sirolimus / Q000378:metabolism; D058570:TOR Serine-Threonine Kinases / Q000378:metabolism*
D000903:Antibiotics, Antineoplastic; D002070:Butadienes; D004791:Enzyme Inhibitors; D009570:Nitriles; D019869:Phosphatidylinositol 3-Kinases; D051057:Proto-Oncogene Proteins c-akt; D020123:Sirolimus; D058570:TOR Serine-Threonine Kinases; C113580:U 0126; C546842:MTOR protein, human